Growth Metrics

United Therapeutics (UTHR) Other Working Capital Changes (2016 - 2026)

United Therapeutics' Other Working Capital Changes history spans 17 years, with the latest figure at $98.2 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 463.7% to $98.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $80.9 million, a 1051.76% increase, with the full-year FY2025 number at $80.9 million, up 1051.76% from a year prior.
  • Other Working Capital Changes hit $98.2 million in Q4 2025 for United Therapeutics, up from -$67.2 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for UTHR hit a ceiling of $184.4 million in Q2 2025 and a floor of -$134.5 million in Q1 2025.
  • Historically, Other Working Capital Changes has averaged $17.7 million across 5 years, with a median of $7.2 million in 2021.
  • Biggest five-year swings in Other Working Capital Changes: surged 648.41% in 2022 and later plummeted 1086.05% in 2024.
  • Tracing UTHR's Other Working Capital Changes over 5 years: stood at $12.6 million in 2021, then surged by 648.41% to $94.3 million in 2022, then tumbled by 124.5% to -$23.1 million in 2023, then dropped by 16.88% to -$27.0 million in 2024, then skyrocketed by 463.7% to $98.2 million in 2025.
  • Business Quant data shows Other Working Capital Changes for UTHR at $98.2 million in Q4 2025, -$67.2 million in Q3 2025, and $184.4 million in Q2 2025.